$6.84
-0.25-3.53%
Last update: Oct 30, 4:16 PM
Agenus Inc (AGEN) Stock Price, Quote, News & History
AGENNASDAQ
U.S. stocks fell Monday, while Kodiak Sciences surged 174% after positive Phase 3 eye disease trial results; several small caps also rallied.
You can purchase shares of Agenus (NASDAQ:AGEN) through any online brokerage.
Other companies in Agenus’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Agenus has a consensus price target of $18.43.
The stock price for Agenus (NASDAQ: AGEN) is $6.7769 last updated October 30, 2026 at 4:16 PM EDT.
There are no upcoming dividends for Agenus.
Agenus does not have any upcoming earnings scheduled.
There is no upcoming split for Agenus.
Agenus is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to...
